INTS Competitors & Alternatives
Compare Intensity Therapeutics, Inc. Common stock with similar stocks in the same industry
Biotechnology
INTS
Main Stock$3.71
Tradestie Score
56
Market Cap
$12.65M
Analyst Upside
+568.5%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.71
|
$133.50M | - | 58 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.00
|
$110.20M | - | 57 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$28.17
|
$76.55M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.55
|
$71.69M | - | 56 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.74
|
$67.94M | - | 59 | Compare |
|
AIRE
reAlpha Tech Corp. Common Stock
|
$2.11
|
$64.14M | - | 46 | Compare |
|
IXHL
Incannex Healthcare Limited American Depositary Shares
|
$3.73
|
$40.49M | - | 53 | Compare |
|
MSAI
MultiSensor AI Holdings, Inc. Common Stock
|
$5.79
|
$22.52M | - | 54 | Compare |
|
FEMY
Femasys Inc. Common Stock
|
$3.84
|
$16.15M | - | 53 | Compare |
|
PCSA
Processa Pharmaceuticals, Inc. Common
|
$2.09
|
$11.06M | - | 43 | Compare |
More INTS Analysis
Data updated: Jun 16, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry